KCNT1-Related Epilepsy

Neurology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Actio Biosciences
Actio BiosciencesCA - San Diego
1 program
1
ABS-1230Phase 11 trial
Active Trials
NCT07156201RecruitingEst. Mar 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Actio BiosciencesABS-1230

Clinical Trials (1)

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

Start: Aug 2025Est. completion: Mar 2026
Phase 1Recruiting

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space